Influenza hemagglutinin and neuraminidase variants

Details for Australian Patent Application No. 2005248377 (hide)

Owner The Government of the United States of America MedImmune, LLC

Inventors Kemble, George; Murphy, Brian; Yang, Chin-Fen; Subbarao, Kanta

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005248377

PCT Pub. Number WO2005/116260

Priority 60/657,554 28.02.05 US; 60/574,553 25.05.04 US

Filing date 20 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 24 March 2011

International Classifications

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/44 (2006.01) Mutation or genetic engineering

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/116260 Priority application(s): WO2005/116260

2 October 2008 Alteration of Name

  The name of the applicant has been altered to The Government of the United States of America; MedImmune, LLC

24 March 2011 Application Accepted

  Published as AU-B-2005248377

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005248389-Treatment of neurodegenerative disease through intracranial delivery of siRNA

2005248375-Influenza hemagglutinin and neuraminidase varians